Stability of 21 Antihypertensive Drugs in Serum Collected in Standard (Non-Gel) Serum Tubes versus Tubes Containing a Gel Separator.
Therapeutic drug monitoring (TDM) of antihypertensive drugs is being increasingly used to optimize treatment and to assess non-adherence. Separator gels are often used in blood collection tubes to facilitate serum or plasma separation from other blood constituents before analyses. Drug adsorption into the separator gel presents a possible pre-analytical cause of falsely low concentrations or false negative results. Drug-free blood from blood donors was spiked with therapeutic concentrations of 21 antihypertensive drugs, transferred to serum tubes with and without separator gel (Vacuette Gel Plastic Tubes and Plain Serum Plastic Tubes, respectively), and centrifuged. Serum was collected immediately after centrifugation and after 24 and 72 h of room temperature storage, samples were analyzed in triplicates using LC-MS/MS. Serum samples collected immediately after centrifugation or 24 h after, had the same drug concentrations in the gel and non-gel tubes. After 72 h of room temperature storage, verapamil and lercanidipine serum concentrations were 43% and 29%, respectively, lower in gel tubes than non-gel tubes. Canrenone, diltiazem, and bendroflumethiazide showed between 10 and 20% concentration loss in gel tubes, compared to non-gel tubes, with the two latter observed as unstable in non-gel tubes. Except for verapamil, lercanidipine, and canrenone, which showed substantial concentration loss in gel tubes, gel tubes may be used for TDM purposes for the most commonly used antihypertensive drugs. Transferring serum to gel-free containers immediately after centrifugation minimizes concentration loss; however, bendroflumethiazide and diltiazem are generally unstable at room temperature.